IP Library › Granted Patent US 12,383,615
Granted Patent B2
US 12,383,615 · App. 18/614,158 · Granted Aug 12, 2025

Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods

Inventors: Robert Kotin (Cambridge, MA); Sebastian Aguirre Kozlouski (Cambridge, MA); Carolyn Pelletier (Salem, MA)
Assignee: Carbon Biosciences, Inc.
A61K39/23A61K2039/5256C12N2750/14322C12N2750/14334C12N2750/14362
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,615
App. No.
18/614,158
Granted
Aug 12, 2025
Kind
B2
Abstract

The present disclosure provides technologies comprising compositions, preparations, constructs, and methods comprising a protoparvovirus variant VP1 capsid polypeptide.

Claims (45)

1. A construct comprising a VP1 capsid coding sequence operably linked to an expression control sequence, wherein the VP1 capsid coding sequence encodes a protoparvovirus variant VP1 capsid polypeptide having an amino acid sequence that:

(i) shows at least 98% sequence identity to SEQ ID NO: 104, or

(ii) shows at least 98% sequence identity to SEQ ID NO: 107, wherein the protoparvovirus variant VP1 capsid polypeptide lacks an amino acid sequence as set forth in SEQ ID NO: 1.

2. The construct of claim 1 , further comprising a sequence that encodes a protoparvovirus VP2 capsid polypeptide.

3. The construct of claim 2 , wherein the construct includes sequences that direct transcription and/or translation start such that the protoparvovirus VP2 capsid polypeptide is present in excess of the protoparvovirus variant VP1 capsid polypeptide.

4. The construct of claim 3 , wherein the VP1 capsid coding sequence comprises fewer translation initiation sequence(s) across the length of the VP1 capsid coding sequence that encodes the protoparvovirus variant VP1 capsid polypeptide relative to the protoparvovirus reference VP1 capsid coding sequence.

5. The construct of claim 1 , wherein the construct further comprises a nucleic acid sequence that encodes one or more heterologous peptides having a length from about 10 amino acids to 20 amino acids.

6. The construct of claim 1 , wherein the expression control sequence comprises a promoter.

7. The construct of claim 1 , wherein the construct further comprises a 5′ untranslated region (UTR) sequence.

8. The construct of claim 7 , wherein the 5′ UTR further comprises either a (i) nucleotide spacer sequence or (ii) a Kozak consensus sequence or both.

9. A kit comprising the construct of claim 1 and a construct comprising a coding sequence encoding a least one capsid replication protein of a protoparvovirus operably linked to an expression control sequence for expression in a host cell.

10. A nucleic acid construct comprising a sequence that encodes a protoparvovirus variant VP1 capsid polypeptide, wherein the protoparvovirus variant VP1 capsid polypeptide has an amino acid sequence having at least 98% identity to SEQ ID NOs: 104 or 107, and wherein the protoparvovirus variant VP1 capsid polypeptide lacks an amino acid sequence as set forth in SEQ ID NO: 1.

11. A protoparvovirus variant VP1 capsid polypeptide having an amino acid sequence that:

(i) shows at least 98% sequence identity to SEQ ID NO: 104, or

(ii) shows at least 98% sequence identity to SEQ ID NO: 107,

wherein the protoparvovirus variant VP1 capsid polypeptide lacks an amino acid sequence as set forth in SEQ ID NO: 1.

12. A virion comprising:

(1) a protoparvovirus variant VP1 capsid polypeptide having an amino acid sequence that:

(i) shows at least 98% sequence identity to SEQ ID NO: 104, or

(ii) shows at least 98% sequence identity to SEQ ID NO: 107,

wherein the protoparvovirus variant VP1 capsid polypeptide lacks an amino acid sequence as set forth in SEQ ID NO: 1; and

(2) a heterologous nucleic acid sequence comprising:

(i) a transgene coding sequence, and

(ii) at least one inverted terminal repeat (ITR).

13. The virion of claim 12 , wherein the protoparvovirus variant VP1 capsid polypeptide comprises an insertion of one or more heterologous peptides having a length of from 10 amino acids to 20 amino acids.

14. The virion of claim 12 , wherein the transgene coding sequence is operably linked to a transgene promoter, optionally placed between two ITRs.

15. The virion of claim 12 , wherein the protoparvovirus variant VP1 capsid polypeptide is phosphorylated.

16. A composition comprising the virion of claim 12 .

17. The composition of claim 16 , wherein the composition is a pharmaceutical composition.

18. A host cell comprising the virion of claim 12 .

19. A method of preventing or treating a disease, comprising:

administering to a subject in need thereof an effective amount of virion according to claim 12 .

20. A method of producing the virion according to claim 12 , comprising:

(1) providing one or more of the following:

(i) a first construct comprising at least one ITR nucleotide sequence, optionally further comprising a heterologous nucleic acid operably linked to a promoter for expression in a target cell,

(ii) a second construct comprising a construct comprising a VP1 capsid coding sequence operably linked to an expression control sequence, wherein the VP1 capsid coding sequence encodes a protoparvovirus variant VP1 capsid polypeptide having an amino acid sequence that:

(a) shows at least 98% sequence identity to SEQ ID NO: 104, or

(b) shows at least 98% sequence identity to SEQ ID NO: 107,

wherein the protoparvovirus variant VP1 capsid polypeptide lacks an amino acid sequence as set forth in SEQ ID NO: 1; and

(2) introducing the first construct and/or the second construct into a host cell, and

(3) maintaining said host cell under conditions such that the virion is produced.

21. The method of claim 20 , further comprising (4) providing a third construct comprising:

(A) at least one capsid replication protein of protoparvovirus operably linked to an expression control sequence for expression in a host cell,

(B) at least one ITR replication protein of an AAV, optionally wherein the at least one ITR replication protein of an AAV comprises (a) a Rep52 or a Rep40 coding sequence operably linked to an expression control sequence for expression in a host cell, and/or (b) a Rep78 or a Rep68 coding sequence operably linked to an expression control sequence for expression in a host cell, or

(C) a combination of (A) and (B).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2024
From: KOTIN, ROBERT; KOZLOUSKI, SEBASTIAN AGUIRRE; PELLETIER, CAROLYN
To: CARBON BIOSCIENCES, INC.
Reel/Frame 067637/0267 →
Continuity (3)
Provisional Application 63545449 · Oct 24, 2023
Provisional Application 63454259 · Mar 23, 2023
Related Publication 20240358820A1 · Oct 31, 2024
References Cited (400)
US 3687808A · Merigan et al. · 1972 [cited by applicant]
US 4845205A · Huynh Dinh et al. · 1989 [cited by applicant]
US 4981957A · Lebleu et al. · 1991 [cited by applicant]
US 4987071A · Cech et al. · 1991 [cited by applicant]
US 5116742A · Cech et al. · 1992 [cited by applicant]
US 5118800A · Smith et al. · 1992 [cited by applicant]
US 5122458A · Post et al. · 1992 [cited by applicant]
US 5130302A · Spielvogel et al. · 1992 [cited by applicant]
US 5134066A · Rogers et al. · 1992 [cited by applicant]
US 5168062A · Stinski · 1992 [cited by applicant]
US 5175273A · Bischofberger et al. · 1992 [cited by applicant]
US 5319080A · Leumann · 1994 [cited by applicant]
US 5359044A · Cook et al. · 1994 [cited by applicant]
US 5367066A · Urdea et al. · 1994 [cited by applicant]
US 5432272A · Benner · 1995 [cited by applicant]
US 5457187A · Gmeiner et al. · 1995 [cited by applicant]
US 5457191A · Cook et al. · 1995 [cited by applicant]
US 5459255A · Cook et al. · 1995 [cited by applicant]
US 5478745A · Samulski et al. · 1995 [cited by applicant]
US 5484908A · Froehler et al. · 1996 [cited by applicant]
US 5502177A · Matteucci et al. · 1996 [cited by applicant]
US 5525711A · Hawkins et al. · 1996 [cited by applicant]
US 5552157A · Yagi et al. · 1996 [cited by applicant]
US 5552540A · Haralambidis · 1996 [cited by applicant]
US 5565213A · Nakamori et al. · 1996 [cited by applicant]
US 5567434A · Szoka, Jr. · 1996 [cited by applicant]
US 5580703A · Kotin et al. · 1996 [cited by applicant]
US 5587469A · Cook et al. · 1996 [cited by applicant]
US 5594121A · Froehler et al. · 1997 [cited by applicant]
US 5596091A · Switzer · 1997 [cited by applicant]
US 5614617A · Cook et al. · 1997 [cited by applicant]
US 5656016A · Ogden · 1997 [cited by applicant]
US 5681941A · Cook et al. · 1997 [cited by applicant]
US 5697899A · Hillman et al. · 1997 [cited by applicant]
US 5738868A · Shinkarenko · 1998 [cited by applicant]
US 5741516A · Webb et al. · 1998 [cited by applicant]
US 5750692A · Cook et al. · 1998 [cited by applicant]
US 5770219A · Chiang et al. · 1998 [cited by applicant]
US 5779708A · Wu · 1998 [cited by applicant]
US 5783208A · Venkateshwaran et al. · 1998 [cited by applicant]
US 5795587A · Gao et al. · 1998 [cited by applicant]
US 5797898A · Santini, Jr. et al. · 1998 [cited by applicant]
US 6015886A · Dale et al. · 2000 [cited by applicant]
US 6147200A · Manoharan et al. · 2000 [cited by applicant]
US 6166197A · Cook et al. · 2000 [cited by applicant]
US 6222025B1 · Cook et al. · 2001 [cited by applicant]
US 6235887B1 · Froehler et al. · 2001 [cited by applicant]
US 6380368B1 · Froehler et al. · 2002 [cited by applicant]
US 6503717B2 · Case et al. · 2003 [cited by applicant]
US 6528640B1 · Beigelman et al. · 2003 [cited by applicant]
US 6534261B1 · Cox, III et al. · 2003 [cited by applicant]
US 6599692B1 · Case et al. · 2003 [cited by applicant]
US 6617438B1 · Beigelman et al. · 2003 [cited by applicant]
US 6639062B2 · Manoharan et al. · 2003 [cited by applicant]
US 6689558B2 · Case · 2004 [cited by applicant]
US 6723551B2 · Kotin et al. · 2004 [cited by applicant]
US 6855314B1 · Chiorini et al. · 2005 [cited by applicant]
US 7045610B2 · Dempcy et al. · 2006 [cited by applicant]
US 7067317B2 · Rebar et al. · 2006 [cited by applicant]
US 7252997B1 · Hallek · 2007 [cited by examiner]
US 7262054B2 · Jamieson et al. · 2007 [cited by applicant]
US 7271002B2 · Kotin et al. · 2007 [cited by applicant]
US 7427672B2 · Imanishi et al. · 2008 [cited by applicant]
US 7495088B1 · Brakel et al. · 2009 [cited by applicant]
US 7951925B2 · Ando et al. · 2011 [cited by applicant]
US 8021867B2 · Smith et al. · 2011 [cited by applicant]
US 8110379B2 · DeKelver et al. · 2012 [cited by applicant]
US 8119381B2 · Smith et al. · 2012 [cited by applicant]
US 8124369B2 · Smith et al. · 2012 [cited by applicant]
US 8129134B2 · Smith et al. · 2012 [cited by applicant]
US 8133697B2 · Smith et al. · 2012 [cited by applicant]
US 8143015B2 · Smith et al. · 2012 [cited by applicant]
US 8143016B2 · Smith et al. · 2012 [cited by applicant]
US 8148098B2 · Smith et al. · 2012 [cited by applicant]
US 8163514B2 · Smith et al. · 2012 [cited by applicant]
US 8304222B1 · Smith et al. · 2012 [cited by applicant]
US 8507267B2 · Chiorini et al. · 2013 [cited by applicant]
US 8586526B2 · Gregory et al. · 2013 [cited by applicant]
US 8697359B1 · Zhang · 2014 [cited by applicant]
US 8771945B1 · Zhang · 2014 [cited by applicant]
US 8771985B2 · Cui et al. · 2014 [cited by applicant]
US 8795965B2 · Zhang · 2014 [cited by applicant]
US 8865406B2 · Zhang et al. · 2014 [cited by applicant]
US 8871445B2 · Cong et al. · 2014 [cited by applicant]
US 10266850B2 · Doudna et al. · 2019 [cited by applicant]
US 10793835B2 · Yan et al. · 2020 [cited by applicant]
US 20060166363A1 · Zolotukhin · 2006 [cited by examiner]
US 20100218264A1 · Cui et al. · 2010 [cited by applicant]
US 20110059502A1 · Chalasani · 2011 [cited by applicant]
US 20110091502A1 · Delwart et al. · 2011 [cited by applicant]
US 20110265198A1 · Gregory et al. · 2011 [cited by applicant]
US 20130122591A1 · Cost et al. · 2013 [cited by applicant]
US 20130137104A1 · Cost et al. · 2013 [cited by applicant]
US 20130177960A1 · Rebar · 2013 [cited by applicant]
US 20130177983A1 · Rebar · 2013 [cited by applicant]
US 20130189265A1 · Salome et al. · 2013 [cited by applicant]
US 20140068797A1 · Doudna et al. · 2014 [cited by applicant]
US 20140170753A1 · Zhang · 2014 [cited by applicant]
US 20150056705A1 · Conway et al. · 2015 [cited by applicant]
US 20150159172A1 · Miller et al. · 2015 [cited by applicant]
US 20170191078A1 · Zhang et al. · 2017 [cited by applicant]
US 20170356008A1 · Lubelski et al. · 2017 [cited by applicant]
US 20190203229A1 · Engelhardt et al. · 2019 [cited by applicant]
US 20190382452A1 · Samulski et al. · 2019 [cited by applicant]
US 20210079421A1 · Yan et al. · 2021 [cited by applicant]
US 20240002882A1 · Yan et al. · 2024 [cited by applicant]
US 20240066080A1 · Kotin et al. · 2024 [cited by applicant]
US 20240358820A1 · Kotin · 2024 [cited by examiner]
EP 1275658A1 · 2003 [cited by applicant]
JP 2020062045A · 2020 [cited by applicant]
WO WO9810088A1 · 1998 [cited by applicant]
WO WO05073384A2 · 2005 [cited by applicant]
WO WO0612414A2 · 2006 [cited by applicant]
WO WO2012030683A2 · 2012 [cited by applicant]
WO WO2013163628A2 · 2013 [cited by applicant]
WO WO2015070083A1 · 2015 [cited by applicant]
WO WO2015138510A1 · 2015 [cited by applicant]
WO WO2016073990A2 · 2016 [cited by applicant]
WO WO2017079673A1 · 2017 [cited by applicant]
WO WO2017152149A1 · 2017 [cited by applicant]
WO WO2019169233A1 · 2019 [cited by applicant]
WO WO2022140683A1 · 2022 [cited by applicant]
WO WO2024196965A1 · 2024 [cited by applicant]
WO WO2024197242A1 · 2024 [cited by applicant]
Alignment of SEQ 89 with PIR_80 db access No. VCPVCD by Parrish et al. 1990. [cited by examiner]
Alignment of SEQ 91 with UniProt db access No. A0A1S5VGK8_9VIRU by Mollerup et al. 2017. [cited by examiner]
Alignment of SEQ 93 with PIR_80 db access No. VCPVCD by Parrish et al. 1990. [cited by examiner]
Alignment of SEQ 94 with PIR_80 db access No. VCPVCD by Parrish et al. 1990. [cited by examiner]
Alignment of SEQ 89 with geneseq db access No. AZH07203 by Delwart et al. 2011. [cited by examiner]
Parrish et al. (Virology. 1988; 166: 293-307. [cited by examiner]
Ilyas et al. (Viruses. 2018; 10, 22; doi:10.3390/v10010022). [cited by examiner]
Martella et al. (Emerging Infectious Diseases. 2018; 24 (6): 1061-1068). [cited by examiner]
Aach, J. et al., CasFinder: Flexible algorithm for identifying specific Cas9 targets in genomes, bioRxiv, 8 pages, (2014). [cited by applicant]
Agbandje-McKenna, M. et al., Functional implications of the structure of the murine parvovirus, minute virus of mice, Structure, 6(11):1369-1381 (1998). [cited by applicant]
Airenne, K.J. et al., Baculovirus: an Insect-derived Vector for Diverse Gene Transfer Applications, Mol. Ther., 21(4):739-749, (2013). [cited by applicant]
Allison, A.B. et al., Single Mutations in the VP2 300 Loop Region of the Three-Fold Spike of the Carnivore Parvovirus Capsid Can Determine Host Range, J. Virol., 90(2):753-767 (2015). [cited by applicant]
Altschul, S.F. et al., Basic local alignment search tool, J. Mol. Biol., 215(3):403-410 (1990). [cited by applicant]
Ame, J.C. et al., A bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA. structure and expression of the mouse PARP-2 gene, J. Biol. Chem., 276(14):11092-11099 (20… [cited by applicant]
Angelova, A.L. et al., Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity, Viruses, 9(12):382 (2017). [cited by applicant]
Antoniou, M.N. et al., Optimizing retroviral gene expression for effective therapies, Hum. Gene. Ther., 24(4):363-374 (2013). [cited by applicant]
Ardestani, S. et al., Membrane versus soluble isoforms of TNF-a exert opposing effects on tumor growth and survival of tumor-associated myeloid cells, Cancer Res., 73(13):3938-3950 (2013). [cited by applicant]
Bacon, B.R. et al., Molecular medicine and hemochromatosis: at the crossroads, Gastroenterology, 116(1):193-207 (1999). [cited by applicant]
Bae, S. et al., Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics, 30(10):1473-1475 (2014). [cited by applicant]
Bagella, L. et al., Cloning of murine CDK9/PITALRE and its tissue-specific expression in development, J. Cell. Physiol, 177(2):206-213 (1998). [cited by applicant]
Baggio, L.L. and Drucker, D.J., Biology of incretins: GLP-1 and GIP, Gastroenterology, 132(6):131-157 (2007). [cited by applicant]
Bar, S. et al., Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning, PLoS Pathog., 4(8):e1000126 (2008). [cited by applicant]
Bar, S. et al., Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis, PLoS Pathog., 9(9):e1003605 (2013). [cited by applicant]
Bartel, D.P. and Szostak, Isolation of new ribozymes from a large pool of random sequences, J.W., Science, 261(5127):1411-1418 (1993). [cited by applicant]
Batt, D. and Carmichael, G., Characterization of the polyomavirus late polyadenylation signal, Mol Cell Biol., 15(9):4783-4790 (1995). [cited by applicant]
Beirwaltes, W.H., Endocrine imaging in the management of goiter and thyroid nodules: Part I, J. Nucl. Med., 32(7):1455-1461 (1991). [cited by applicant]
Benner, S.A. and Sismour, A.M., Synthetic biology, Nat. Rev. Genet., 6(7):533-543 (2005). [cited by applicant]
Berns, K.I., The Unusual Properties of the AAV Inverted Terminal Repeat, Hum. Gene Ther., 31(9-10):518-523 (2020). [cited by applicant]
Bernstein, E. et al., Role for a bidentate ribonuclease in the initiation step of RNA interference, Nature, 409(6818):363-366 (2001). [cited by applicant]
Bodendorf, U. et al., Nuclear export factor CRM1 interacts with nonstructural proteins NS2 from parvovirus minute virus of mice, J. Virol., 73(9):7769-7779 (1999). [cited by applicant]
Boeda, B. et al., A specific promoter of the sensory cells of the inner ear defined by transgenesis, Hum. Mol. Genet., 10(15):1581-1589 (2001). [cited by applicant]
Bohringer, M. et al., Warum Pentose- und nicht Hexose-Nucleinsauren ??. Teil II. Oligonucleotide aus 2′,3′-Dideoxy-beta-D-glucopyranosyl-Bausteinen (‘Homo-DNS’): Herstellung., Helv. Chim. Acta., 75(5):1416-1477 (1992). [cited by applicant]
Boissel, S. and Scharenberg, A.M., Assembly and characterization of megaTALs for hyperspecific genome engineering applications, Methods Mol. Biol., 1239:171-196 (2015). [cited by applicant]
Boissel, S. et al., megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering, Nucleic Acids Res., 42(4):2591-2601 (2014). [cited by applicant]
Borner, K. et al., Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening, Mol. Ther., 28(4):1016-1032 (2020). [cited by applicant]
Boshart, M. et al., A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus, Cell, 41(2):521-530 (1985). [cited by applicant]
Bourlais, C.L. et al., Ophthalmic drug delivery systems—recent advances, Prog. Retin. Eye Res., 17(1):33-58 (1998). [cited by applicant]
Brockhaus, K. et al., Nonstructural proteins NS2 of minute virus of mice associate in vivo with 14-3-3 protein family members, J. Virol., 70(11):7527-7534 (1996). [cited by applicant]
Brummelkamp, T.R. et al., A system for stable expression of short interfering RNAs in mammalian cells, Science, 296(5567):550-553 (2002). [cited by applicant]
Bull, P.C. et al., The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene, Nat. Genet., 5(4):327-337 (1993). [cited by applicant]
Buning, H. and Srivastava, A., Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors, Mol. Ther. Methods Clin. Dev., 12:248-265 (2019). [cited by applicant]
Callaway, H.M. et al., Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages, J. Virol., 91(2):e01871-16 (2017). [cited by applicant]
Candotti, D. et al., Identification and characterization of persistent human erythrovirus infection in blood donor samples, J. Virol., 78(22):12169-12178, (2004). [cited by applicant]
Canuti, M. et al., Two novel parvoviruses in frugivorous New and Old World bats, PLoS One, 6(12):e29140 (2011). [cited by applicant]
Carillo, H. and Lipman, D., The Multiple Sequence Alignment Problem in Biology, SIAM J. Appl. Math., 48(5):1073-1082 (1988). [cited by applicant]
Carrasco, C. et al., DNA-mediated anisotropic mechanical reinforcement of a virus, PNAS USA, 103(37):13706-13711 (2006). [cited by applicant]
Carrasco, C. et al., Manipulation of the mechanical properties of a virus by protein engineering, PNAS USA, 105(11):4150-4155 (2008). [cited by applicant]
Cater, M.A. et al., Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B), Biochem. J., 401(1):143-153 (2007). [cited by applicant]
Cecchini, S. et al., Reproducible High Yields of Recombinant Adeno-Associated Virus Produced Using Invertebrate Cells in 0.02- to 200-Liter Cultures, Hum. Gene. Ther., 22(8):1021-1030, (2011). [cited by applicant]
Cecchini, S. et al., Toward exascale production of recombinant adeno-associated virus for gene transfer applications, Gene Ther., 15(11):823-830, (2008). [cited by applicant]
Certo, M.T. et al., Coupling endonucleases with DNA end-processing enzymes to drive gene disruption, Nat. Methods, 9(10):973-975 (2012). [cited by applicant]
Chapman, M.S. and Rossmann, M.G., Single-stranded DNA-protein interactions in canine parvovirus, Structure, 3(2):151-162 (1995). [cited by applicant]
Chejanovsky, N. and Carter, B.J., Mutation of a consensus purine nucleotide binding site in the adeno-associated virus rep gene generates a dominant negative phenotype for DNA replication, J. Virol., 64(4):1764-1770 (19… [cited by applicant]
Chen, C.Y. et al., mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation, Mol.… [cited by applicant]
Chen, Q. et al., An AU-rich element in the 3′ untranslated region of the spinach chloroplast petD gene participates in sequence-specific RNA-protein complex formation, Mol. Cell. Biol., 15(4):2010-2018 (1995). [cited by applicant]
Chiu, Y. and Rana, T.M., siRNA function in RNAi: a chemical modification analysis, RNA, 9(9):1034-1048 (2003). [cited by applicant]
Choi, E.Y. et al., Replication of minute virus of mice DNA is critically dependent on accumulated levels of NS2, J. Virol., 79(19):12375-12381 (2005). [cited by applicant]
Choi, J.H. et al., Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons, Mol. Brain., 7:17 (2014). [cited by applicant]
Choi, S.H. et al., Detargeting Lentiviral-Mediated CFTR Expression in Airway Basal Cells Using miR-106b, Genes (Basel), 11(10):1169 (2020). [cited by applicant]
Christensen, J. et al., Minute virus of mice initiator protein NS1 and a host KDWK family transcription factor must form a precise ternary complex with origin DNA for nicking to occur, J. Virol., 75(15):7009-7017 (2001). [cited by applicant]
Christensen, J. et al., Minute virus of mice transcriptional activator protein NS1 binds directly to the transactivation region of the viral P38 promoter in a strictly ATP-dependent manner, J. Virol., 69(9):5422-5430 (1… [cited by applicant]
Chu, G. and Sharp, P.A., SV40 Dna transfection of cells in suspension: analysis of efficiency of transcription and translation of T-antigen, Gene, 13(2):197-202 (1981). [cited by applicant]
Clevers, H., The intestinal crypt, a prototype stem cell compartment, Cell, 154(2):274-284 (2013). [cited by applicant]
Cong, L. et al., Multiplex genome engineering using CRISPR/Cas systems, Science, 339(6121):819-823 (2013). [cited by applicant]
Cotmore, S.F. and Tattersall, P. et al., Encapsidation of minute virus of mice DNA: aspects of the translocation mechanism revealed by the structure of partially packaged genomes, Virology, 336(1):100-112 (2005). [cited by applicant]
Cotmore, S.F. and Tattersall, P., Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice induce 3′-to-5′ genome uncoating and critically impair entry functions, J. Virol., 86(1):69-80 (2012… [cited by applicant]
Cotmore, S.F. et al., Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3′-to-5′ direction from an otherwise intact viral particle, J. Virol., 84(4):1945-19… [cited by applicant]
Cotmore, S.F. et al., The family Parvoviridae, Arch. Virol., 159(5):1239-1247 (2014). [cited by applicant]
Cotmore, S.F. et al., The NS1 polypeptide of the murine parvovirus minute virus of mice binds to DNA sequences containing the motif [ACCA]2-3, J. Virol., 69(3):1652-1660 (1995). [cited by applicant]
Cotmore, S.F. et al., The NS2 polypeptide of parvovirus MVM is required for capsid assembly in murine cells, Virology, 231(2):267-280 (1997). [cited by applicant]
Cotmore, S.F. et al., Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rolling-hairpin replication origin, J. Virol., 74(3):1332-1341 (2000). [cited by applicant]
Cunningham, S.C. et al., Gene delivery to the juvenile mouse liver using AAV2/8 vectors, Mol. Ther., 16(6):1081-1088 (2008). [cited by applicant]
Davis, L. and Maizels, N., Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair, PNAS USA, 111(10):E924-E932 (2014). [cited by applicant]
Davit-Spraul, A. et al., The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects, Semin. Liver. Dis., 30(2):134-146 (2010). [cited by applicant]
De Almeida, S.F. and De Sousa, M., The unfolded protein response in hereditary haemochromatosis, J. Cell. Mol. Med., 12(2):421-434 (2008). [cited by applicant]
Dekelver, R.C. et al., Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome, Genome Res., 20(8):11… [cited by applicant]
Demirci, S. et al., Gene therapy for sickle cell disease: An update, Cytotherapy, 20(7):899-910 (2018). [cited by applicant]
Deng, X. et al., DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells, J. Virol., 91(1):e01831-16 (2016). [cited by applicant]
Deng, X. et al., Establishment of a Recombinant AAV2/HBoV1 Vector Production System in Insect Cells, Genes (Basel), 11(4):439, (2020). [cited by applicant]
Deng, X. et al., Human Parvovirus Infection of Human Airway Epithelia Induces Pyroptotic Cell Death by Inhibiting Apoptosis, J. Virol., 91(24):e01533-17 (2017). [cited by applicant]
Deng, X. et al., In vitro modeling of human bocavirus 1 infection of polarized primary human airway epithelia, J. Virol., 87(7):4097-4102 (2013). [cited by applicant]
Deng, X. et al., Replication of an Autonomous Human Parvovirus in Non-dividing Human Airway Epithelium is Facilitated through the DNA Damage and Repair Pathways, PLoS Pathog., 12(1):e1005399 (2016). [cited by applicant]
Devereux, J. et al., A comprehensive set of sequence analysis programs for the VAX, Nucleic Acids Res., 12(1 Pt 1):387-395 (1984). [cited by applicant]
Ding, W. et al., rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion, Mol. Ther., 13(4):671-682 (2006). [cited by applicant]
Ding, W. et al., Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia, J. Virol., 77(13):7361-7366 (2003). [cited by applicant]
Doench, J.G. et al., Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat. Biotechnol., 34(2):184-191 (2016). [cited by applicant]
Doerschug, K. et al., First-generation adenovirus vectors shorten survival time in a murine model of sepsis, J. Immunol., 169(11):6539-6545 (2002). [cited by applicant]
Domingo, E., Molecular basis of genetic variation of viruses, Viruses as Populations, 2020:35-71 (2020). [cited by applicant]
Donze, O. and Picard, D., RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase, Nucleic Acids Res., 30(10):e46 (2002). [cited by applicant]
Driskell, R.A. and Engelhardt, J.F., Current status of gene therapy for inherited lung diseases, Annu. Rev. Physiol., 65:585-612 (2003). [cited by applicant]
Duan, D. et al., Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue, J. Virol., 77(8):4751-4759… [cited by applicant]
Duan, D. et al., Dual vector expansion of the recombinant AAV packaging capacity, Methods Mol. Biol., 219:29-51 (2003). [cited by applicant]
Duan, D. et al., Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications, Methods Mol. Med., 76:287-307 (2003). [cited by applicant]
Duclert, A. et al., An 83-nucleotide promoter of the acetylcholine receptor epsilon-subunit gene confers preferential synaptic expression in mouse muscle, PNAS USA, 90(7):3043-3047 (1993). [cited by applicant]
Earley, L.F. et al., Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression, Hum. Gene Ther., 31(3-4):151-162 (2020). [cited by applicant]
Egli, M. et al., Crystal structure of homo-DNA and nature's choice of pentose over hexose in the genetic system, J. Am. Chem. Soc., 128(33):10847-10856 (2006). [cited by applicant]
Eichwald, V. et al., The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells, J. Virol., 76(20):10307-10319 (2002). [cited by applicant]
Elbashir, S.M. et al., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411(6836):494-498 (2001). [cited by applicant]
Elbashir, S.M. et al., RNA interference is mediated by 21- and 22-nucleotide RNAs, Genes. Dev., 15(2):188-200 (2001). [cited by applicant]
Engelhardt, J.F., AAV hits the genomic bull's-eye, Nat. Biotechnol., 24(8):949-950 (2006). [cited by applicant]
Engelhardt, J.F., The lung as a metabolic factory for gene therapy, J. Clin. Invest., 110(4):429-432 (2002). [cited by applicant]
Engelsma, D. et al., A supraphysiological nuclear export signal is required for parvovirus nuclear export, Mol. Biol. Cell., 19(6):2544-2552 (2008). [cited by applicant]
Eschenmoser, A. and Dobler, M., Warum Pentose- und nicht Hexose-Nucleinsauren?? Teil I. Einleitung und Problemstellung, Konformationsanalyse fur Oligonucleotid-Ketten aus 2′,3′-Dideoxyglucopyranosyl-Bausteinen (‘Homo-DN… [cited by applicant]
Eschenmoser, A., Chemical etiology of nucleic acid structure, Science, 284(5423):2118-2124 (1999). [cited by applicant]
Ezquer, F. et al., Hereditary hemochromatosis: an opportunity for gene therapy, Biol. Res., 39(1):113-124 (2006). [cited by applicant]
Fakhiri, J. and Grimm, D., Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses, Mol.Ther., 29(12):3359-3382 (2021). [cited by applicant]
Fakhiri, J. et al., Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses, Mol. Ther. Methods Clin. Dev., 12:202-222, (2019). [cited by applicant]
Feder, J.N. et al., A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat. Genet., 13(4):399-408 (1996). [cited by applicant]
Feder, J.N. et al., The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression, J. Biol. Chem., 272(22):14025-14028 (1997). [cited by applicant]
Fisher, K. et al., Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis, J Virol., 70(1):520-532 (1996). [cited by applicant]
Flotte, T.R. et al., Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway, Mol. Ther., 18(3):594-600 (2010). [cited by applicant]
Fox, L.E. et al., Screen for dominant behavioral mutations caused by genomic insertion of P-element transposons in [cited by applicant]
Frit, P. et al., Alternative end-joining pathway(s): bricolage at DNA breaks, DNA Repair (Amst)., 17:81-97 (2014). [cited by applicant]
Fu, Y. et al., Improving CRISPR-Cas nuclease specificity using truncated guide RNAs, Nat. Biotechnol., 32(3):279-284 (2014). [cited by applicant]
Gaj, T. et al., Enhancing the specificity of recombinase-mediated genome engineering through dimer interface redesign, J. Am. Chem. Soc., 136(13):5047-5056 (2014). [cited by applicant]
Geletneky, K. et al., Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial, Mol. Ther., 25(12):2620-2634 (2017). [cited by applicant]
GenBank Accession No. J04617.1, Human elongation factor EF-1-alpha gene, complete cds, 3 pages, (1994). [cited by applicant]
Gilham, D.E. et al., Cytokine stimulation and the choice of promoter are critical factors for the efficient transduction of mouse T cells with HIV-1 vectors, J. Gene. Med., 12(2):129-136 (2010). [cited by applicant]
Gill, D.R. et al., Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter, Gene. Ther., 8(20):1539-1546 (2001). [cited by applicant]
Gil-Ranedo, J. et al., The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly, PLoS Pathog., 11(6):e1004920 (2015). [cited by applicant]
Gochee, P.A. et al., A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation, Gastroenterology, 122(3):646-651 (2002). [cited by applicant]
Goodman, L.B. et al., Binding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection, J. Virol., 84(10):4969-4978 (2010). [cited by applicant]
Gossen, M. et al., Tight control of gene expression in mammalian cells by tetracycline-responsive promoters., Proc. Natl. Acad. Sci. USA, 89:5547-5551 (1992). [cited by applicant]
Gossen, M. et al., Transcriptional activation by tetracyclines in mammalian cells, Science, 268:1766-1769 (1995). [cited by applicant]
Graham, F.L. and Van Der Eb, A.J., A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology, 52(2):456-467 (1973). [cited by applicant]
Gray, S.J. et al., Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors, Hum. Gene. Ther., 22(9):1143-1153 (2… [cited by applicant]
Grekova, S. et al., Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism, J. Virol., 84(1):516-531 (2010). [cited by applicant]
Grieger, J.C. et al., Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector, Mol. Ther., 24(2… [cited by applicant]
Groebke, K. et al., Warum Pentose-und nicht Hexose-Nucleinsauren??. Teil V. (Purin-Purin)-Basenpaarung in der homo-DNS-Reihe: Guanin, Isoguanin, 2,6-Diaminopurin und Xanthin, Helv. Chim. Acta., 81(3-4):375-474 (1998). [cited by applicant]
Gu, Z. et al., NF-Y controls transcription of the minute virus of mice P4 promoter through interaction with an unusual binding site, J. Virol., 69(1):239-246 (1995). [cited by applicant]
Guggino, W.B. et al., A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System, Hum. Gene. Ther. Clin. Dev., 28(3):145-1… [cited by applicant]
Halder, S. et al., Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids, J. Virol., 87(9):5128-5140 (2013). [cited by applicant]
Hammond, S.M. et al., Post-transcriptional gene silencing by double-stranded RNA, Nat. Rev. Genet., 2(2):110-119 (2001). [cited by applicant]
Harper, S.Q. et al., Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy, Nat. Med., 8(3):253-261 (2002). [cited by applicant]
Harraz, M.M. et al., MKK6 phosphorylation regulates production of superoxide by enhancing Rac GTPase activity, Antioxid. Redox. Signal., 9(11):1803-1813 (2007). [cited by applicant]
Harvey, D. M. and Caskey, C. T., Inducible Control of Gene Expression: Prospects for Gene Therapy, Curr. Opin. Chem. Biol., 2:512-518 (1998). [cited by applicant]
Haseloff, J. and Gerlach, W.L., Simple RNA enzymes with new and highly specific endoribonuclease activities, Nature, 334(6183):585-591 (1988). [cited by applicant]
Haut, D.D. and Pintel, D.J., Inclusion of the NS2-specific exon in minute virus of mice mRNA is facilitated by an intronic splicing enhancer that affects definition of the downstream small intron, Virology, 258(1):84-94… [cited by applicant]
Havens, M.A. and Hastings, M.L., Splice-switching antisense oligonucleotides as therapeutic drugs, Nucleic Acids Res., 44(14):6549-6563 (2016). [cited by applicant]
Hayakawa, J. et al., Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice, Stem Cells, 27(1):175-182 (2009). [cited by applicant]
Heigwer, F. et al., E-CRISP: fast CRISPR target site identification, Nat. Methods, 11(2):122-123 (2014). [cited by applicant]
Hendrickson, B.A. et al., Clinical aspects and pathophysiology of inflammatory bowel disease, Clin. Microbiol. Rev., 15(1):79-94 (2002). [cited by applicant]
Henry, A.A. and Romesberg, F.E., Beyond A, C, G and T: augmenting nature's alphabet, Curr. Opin. Chem. Biol., 7(6):727-733 (2003). [cited by applicant]
Heuberger, B.D. et al., A pre-RNA candidate revisited: both enantiomers of flexible nucleoside triphosphates are DNA polymerase substrates, J. Am. Chem. Soc., 130(2):412-413 (2008). [cited by applicant]
Hingtgen, S.D. et al., Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy, Physiol. Genomics, 26(3):180-191 (2006). [cited by applicant]
Hirao, I., Unnatural base pair systems for DNA/RNA-based biotechnology, Curr. Opin. Chem. Biol., 10(6):622-627 (2006). [cited by applicant]
Hsu, M.Y. et al., Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation, Lab. Invest., 88(8):842-855 (2008). [cited by applicant]
Huang, Q. et al., Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia, PLoS Pathog., 8(8):e1002899 (2012). [cited by applicant]
Hueffer, K. et al., Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses, J. Virol., 77(18):10099-10105 (2003). [cited by applicant]
Hueffer, K. et al., The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor, J. Virol., 77(3):1718-1726 (2003). [cited by applicant]
Hunziker, J. et al., Warum pentose-und nicht hexose-nucleinsauren? Teil III. Oligo(2′,3′-dideoxy-beta-D-glucopyranosyl) nucleotide (‘homo-DNS’): Paarungesigenschaften., Helv. Chim. Acta., 76(1):259-352 (1993). [cited by applicant]
Husain, T. et al., Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters, Gene. Ther., 16(7):927-932 (2009). [cited by applicant]
Ikeda, Y. et al., Gene transduction efficiency in cells of different species by HIV and EIAV vectors, Gene. Ther., 9(14):932-938 (2002). [cited by applicant]
International Search Report for PCT/US2021/065108, filed Dec. 23, 2021, 3 pages, (mailed Apr. 11, 2022). [cited by applicant]
Iyama, T. and Wilson, D.M., Dna repair mechanisms in dividing and non-dividing cells, DNA Repair (Amst)., 12(8):620-636 (2013). [cited by applicant]
Jinek, M. et al., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 337(6096):816-821 (2012). [cited by applicant]
Jones, M.S. et al., New DNA viruses identified in patients with acute viral infection syndrome, J. Virol., 79(13):8230-8236 (2005). [cited by applicant]
Joyce, G.F. et al., The case for an ancestral genetic system involving simple analogues of the nucleotides, PNAS USA, 84(13):4398-4402 (1987). [cited by applicant]
Kailasan, S. et al., Parvovirus Family Conundrum: What Makes a Killer? Annu. Rev. Virol., 2(1):425-450 (2015). [cited by applicant]
Kajigaya, S. et al., Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions, Proc. Natl. Acad. Sci. USA, 88(11):4646-4650, (1991). [cited by applicant]
Kallunki, T. et al., How to Choose the Right Inducible Gene Expression System for Mammalian Studies? Cells, 8(8):796 (2019). [cited by applicant]
Kawasaki, A.M et al., Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets, J. Med. Chem., 36(7):831-841 (1… [cited by applicant]
Keiser, N.W. et al., Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in Hela cells, Hum. Gene. Ther., 22(11):1433-1444 (2011). [cited by applicant]
Kilham, L. and Oliver, L.J., A latent virus of rats isolated in tissue culture, Virology, 7(4):428-437 (1959). [cited by applicant]
King, J.A. et al., DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids, EMBO J., 20(12):3282-3291 (2001). [cited by applicant]
Klein, R.L. et al., Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain, Exp. Neurol., 176(1):66-74 (2002). [cited by applicant]
Komor, A.C. et al., Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage, Nature, 533(7603):420-424 (2016). [cited by applicant]
Kool, E.T., Replacing the nucleobases in DNA with designer molecules, Acc. Chem. Res., 35(11):936-943 (2002). [cited by applicant]
Kotin, R.M. and Berns, K.I., Organization of adeno-associated virus DNA in latently infected Detroit 6 cells, Virology, 170(2):460-467 (1989). [cited by applicant]
Kotin, R.M. and Snyder, R.O., Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines, Hum. Gene. Ther., 28(4):350-260, (2017). [cited by applicant]
Kotin, R.M et al., Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination, 11(13):5071-5078 (1992). [cited by applicant]
Kotin, R.M. et al., Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19913-qter, Genomics, 10(3):831-834 (1991). [cited by applicant]
Kotin, R.M. et al., Site-specific integration by adeno-associated virus, PNAS USA, 87(6):2211-2215 (1990). [cited by applicant]
Kotin, R.M., Large-scale recombinant adeno-associated virus production, Hum. Mol. Genet., 20(R1):R2-R6, (2011). [cited by applicant]
Kriegler, M. et al., A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, 53(1):45-53 (1988). [cited by applicant]
Krueger, A.T. et al., Synthesis and properties of size-expanded DNAs: toward designed, functional genetic systems, Acc. Chem. Res., 40(2):141-150 (2007). [cited by applicant]
Lahtinen, A. et al., Serodiagnosis of primary infections with human parvovirus 4, Finland, Emerg. Infect. Dis., 17(1):79-82 (2011). [cited by applicant]
Lai, Y. et al., Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors, Nat. Biotechnol., 23(11):1435-1439 (2005). [cited by applicant]
Lau, S.K.P. et al., Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4, J. Gen. Virol., 89(Pt 8)1840-1848 (2008). [cited by applicant]
Lee, H. et al., Transferrin receptor binds virus capsid with dynamic motion, Proc. Natl. Acad. Sci. USA., 116(41):20462-20471 (2019). [cited by applicant]
Lee, N.S. et al., Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells, Nat Biotechnol., 20(5):500-505 (2002). [cited by applicant]
Levine, B. et al., Development of autophagy inducers in clinical medicine, J. Clin. Invest., 125(1):14-24 (2015). [cited by applicant]
Levitt, N. el al, Definition of an efficient synthetic poly(A) site, Genes Dev. 3(7):1019-1025 (1989). [cited by applicant]
Li, A. et al., A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing, Mol. Ther. Methods Clin. Dev., 12:111-122 (2018). [cited by applicant]
Limanskiy, V. et al., Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease, World. J. Gastroenterol., 25(18):2177-2187 (2019). [cited by applicant]
Limbach, P.A. et al., Summary: the modified nucleosides of RNA, Nucleic Acids Res., 22(12):2183-2196 (1994). [cited by applicant]
Liu, X. et al., Analysis of adeno-associated virus progenitor cell transduction in mouse lung, Mol. Ther., 17(2):285-293 (2009). [cited by applicant]
Liu, X. et al., Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates, Mol. Ther., 15(12):2114-2123 (2007). [cited by applicant]
Liu, X. et al., Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing, Nat. Biotechnol., 20(1):47-52 (2002). [cited by applicant]
Liu, X. et al., Species-specific differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction, Am. J. Respir. Cell. Mol. Biol., 34(1):56-64 (2006). [cited by applicant]
Liu, X et al., Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway ep… [cited by applicant]
Liu, X. et al., Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions, J. Virol., 78(8):4165-4175 (2004). [cited by applicant]
Liu, Y. et al., Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability, J. Biol. Chem., 286(15):13161-13170 (2011). [cited by applicant]
Liu, Y. et al., Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo, Experimental and Molecular Medicine, 39(2):170-175 (2007). [cited by applicant]
Lofling, J. et al., Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid, Virology, 440(1):89-96 (2013). [cited by applicant]
Lombardo, E. et al., A beta-stranded motif drives capsid protein oligomers of the parvovirus minute virus of mice into the nucleus for viral assembly, J. Virol., 74(8):3804-3814 (2000). [cited by applicant]
Lopez-Astacio, R.A. et al., Viral Capsid, Antibody, and Receptor Interactions: Experimental Analysis of the Antibody Escape Evolution of Canine Parvovirus, J. Virol., 97(6):e00090-23 (2023). [cited by applicant]
Lopez-Bueno, A. et al., Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness, J. Virol., 78(19):10674-10684 (2004). [cited by applicant]
Lorson, C. et al., Efficient transactivation of the minute virus of mice P38 promoter requires upstream binding of NS1, J. Virol., 70(2):834-842 (1996). [cited by applicant]
Lou, S. et al., Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae, Virology, 422(1):59-69 (2012). [cited by applicant]
Lusby, E. et al., Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA, J. Virol., 34(2):402-409 (1980). [cited by applicant]
Lyi, S.M. et al., Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton, Virology, 456-457:342-353 (2014). [cited by applicant]
Magari, S. R. et al., Pharmacologic control of a humanized gene therapy system implanted into nude mice., J. Clin. Invest., 100:2865-2872 (1997). [cited by applicant]
Makarova, K.S. et al., Evolution and classification of the CRISPR-Cas systems, Nat. Rev. Microbiol., 9(6):467-477 (2011). [cited by applicant]
Mantyla, E. et al., Cytoplasmic Parvovirus Capsids Recruit Importin Beta for Nuclear Delivery, J. Virol., 94(4):e01532-19 (2020). [cited by applicant]
Maroto, B. et al., Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface, J. Virol., 78(19):10685-10694 (2004). [cited by applicant]
Mattei, L.M. et al., Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts, Virology, 442(1):20-27 (2013). [cited by applicant]
Matthews, P.C. et al., Human parvovirus 4 ‘PARV4’ remains elusive despite a decade of study, F1000Res., 6:82 (2017). [cited by applicant]
Mcintosh, B.E. et al., Nonirradiated NOD, B6.SCID II12ry-/-Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells, Stem Cell Reports, 4(2):171-180 (2015). [cited by applicant]
Mcmanus, M.T. et al., Gene silencing using micro-RNA designed hairpins, RNA, 8(6):842-850 (2002). [cited by applicant]
Meriluoto, M. et al., Association of Human Bocavirus 1 Infection with Respiratory Disease in Childhood Follow-up Study, Finland, Emerg. Infect. Dis., 18(2):264-271, (2012). [cited by applicant]
Meszaros, I. et al., Biology of Porcine Parvovirus (Ungulate parvovirus 1), Viruses, 9(12):393 (2017). [cited by applicant]
Meszaros, I. et al., The SAT Protein of Porcine Parvovirus Accelerates Viral Spreading through Induction of Irreversible Endoplasmic Reticulum Stress, J. Virol., 91(16):e00627-17 (2017). [cited by applicant]
Mietzsch, M. et al., Twenty-Five Years of Structural Parvovirology, Viruses, 11(4):362 (2019). [cited by applicant]
Miller, C.L. and Pintel, D.J., Interaction between parvovirus NS2 protein and nuclear export factor Crm1 is important for viral egress from the nucleus of murine cells, J. Virol., 76(7):3257-3266 (2002). [cited by applicant]
Miyagishi, M. and Taira, K., U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells, Nat. Biotechnol., 20(5):497-500 (2002). [cited by applicant]
Mollerup, S. et al., Cutavirus in Cutaneous Malignant Melanoma, Emerg. Infect. Dis., 23(2):363-365 (2017). [cited by applicant]
Morales-Rojas, H. and Kool, E.T., A porphyrin C-nucleoside incorporated into DNA, 4(25):4377-4380 (2002). [cited by applicant]
Mueller, C. et al., Sustained miRNA-mediated Knockdown of Mutant AAT With Simultaneous Augmentation of Wild-type AAT Has Minimal Effect on Global Liver miRNA Profiles, Mol. Ther., 20(3):590-600 (2012). [cited by applicant]
Naeger, L.K. et al., The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious virus production in a cell-type- specific manner, J. Virol., 64(… [cited by applicant]
Naito, Y. et al., CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites, Bioinformatics, 31(7):1120-1123 (2015). [cited by applicant]
Nasir, W. et al., Parvovirus B19 VLP recognizes globoside in supported lipid bilayers, Virology, 456-457:364-369, (2014). [cited by applicant]
Navone, S.E. et al., Human and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survival, Vasc. Cell., 5(1):10 (2013). [cited by applicant]
Negrete, A. and Kotin, R.M., Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales, J. Virol. Methods, 145(2):155-161, (2007). [cited by applicant]
Negrete, A. and Kotin, R.M., Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology, Brief Funct. Genomic Proteomic, 7(4):303-311, (2008). [cited by applicant]
Nemeth, E. et al., Hepcidin is decreased in TFR2 hemochromatosis, Blood, 105(4):1803-1806 (2005). [cited by applicant]
Nemeth, E. et al., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306(5704):2090-2093 (2004). [cited by applicant]
No, D. et al., Ecdysone-inducible gene expression in mammalian cells and transgenic mice, Proc. Natl. Acad. Sci. USA, 93:3346-3351 (1996). [cited by applicant]
Nozoe, M. et al., Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats, Hypertension, 50(1):62-68 (2007… [cited by applicant]
Ochi, K. et al., Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells, Stem Cells Transl. Med., 3(7):792-800 (2014). [cited by applicant]
Ohlfest, J.R. et al., Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system, Blood, 105(7):2691-269… [cited by applicant]
Orkin, S. et al., Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human beta-globin gene, EMBO J., 4(2):453-456 (1985). [cited by applicant]
Ostedgaard, L.S. et al., A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia, PNAS USA, 102(8):2952-2957 (2005). [cited by applicant]
Otting, G. et al., Warum Pentose- und nicht Hexose-Nucleinsauren??. Teil VI. ‘Homo-DNS’: 1H-, 13C-, 31P- und 15N-NMR-spektroskopische Untersuchung von ddGlc(A-A-A-A-A-T-T-T- T-T) in wassriger Losung, Helv. Chim. Acta., … [cited by applicant]
Paddison, P.J. et al., Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells, Genes Dev., 16(8):948-958 (2002). [cited by applicant]
Panning, M. et al., Novel human parvovirus 4 genotype 3 in infants, Ghana, Emerg. Infect. Dis., 16(7):1143-1146 (2010). [cited by applicant]
Parker, J.S. et al., Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells, J. Virol., 75(8):3896-3902 (2001). [cited by applicant]
Paul, C.P. et al., Effective expression of small interfering RNA in human cells, Nat Biotechnol., 20(5):505-508 (2002). [cited by applicant]
Pearson, W.R. and Lipman, D.J., Improved tools for biological sequence comparison, PNAS USA, 85(8):2444-2448 (1988). [cited by applicant]
Peng, X. et al., The draft genome sequence of the ferret ( [cited by applicant]
Peterson, J.R. et al., Longitudinal noninvasive monitoring of transcription factor activation in cardiovascular regulatory nuclei using bioluminescence imaging, Physiol. Genomics, 33(2):292-299 (2008). [cited by applicant]
Phan, T.G. et al., A new protoparvovirus in human fecal samples and cutaneous T cell lymphomas (mycosis fungoides), Virology, 496:299-305 (2016). [cited by applicant]
Phan, T.G. et al., Acute diarrhea in West African children: diverse enteric viruses and a novel [cited by applicant]
Phan, T.G. et al., New parvovirus in child with unexplained diarrhea, Tunisia, Emerg. Infect. Dis., 20(11):1911-1913 (2014). [cited by applicant]
Pillay, S. et al., Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor, J. Virol., 91(18):e00391-17 (2017). [cited by applicant]
Pintel, D. et al., The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units, Nucleic Acids Res., 11(4):1019-1038 (1983). [cited by applicant]
Ponnazhagan, S. et al., Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes, J. Virol., 72(6):5224-5230, (1998). [cited by applicant]
Porro, F. et al., Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model, EMBO Mol. Med., 9(10):1346-1355 (2017). [cited by applicant]
Powell, S.K. et al., Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy, Discov. Med., 19(102):49-57 (2015). [cited by applicant]
Proudfoot, N.J. et al., Integrating mRNA processing with transcription, Cell, 108(4):501-512 (2002). [cited by applicant]
Qi, L.S. et al., Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression, Cell, 152(5):1173-1183 (2013). [cited by applicant]
Qin, J.Y. et al., Systematic comparison of constitutive promoters and the doxycycline-inducible promoter, PLoS One, 5(5):e10611 (2010). [cited by applicant]
Qiu, J. et al., Human Parvoviruses, Clin. Microbiol. Rev., 30(1):43-113 (2017). [cited by applicant]
Ran, F.A. et al., Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, 154(6):1380-1389 (2013). [cited by applicant]
Rangarajan, S. et al., AAV5-Factor VIII Gene Transfer in Severe Hemophilia A, N. Engl. J. Med., 377(26):2519-2530 (2017). [cited by applicant]
Riolobos, L. et al., Viral oncolysis that targets Raf-1 signaling control of nuclear transport, J. Virol., 84(4):2090-2099 (2010). [cited by applicant]
Rivera, S. et al., Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia, Blood., 105(4):1797-1802 (2005). [cited by applicant]
Roetto, A. et al., Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat. Genet., 33(1):21-22 (2003). [cited by applicant]
Rogers, C.S. et al., Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer, J. Clin. Invest., 118(4):1571-1577 (2008). [cited by applicant]
Ros, C. et al., Protoparvovirus Cell Entry, Viruses, 9(11):313, (2017). [cited by applicant]
Ruiz, Z. et al., Differential roles for the C-terminal hexapeptide domains of NS2 splice variants during MVM infection of murine cells, Virology, 349(2):382-395 (2006). [cited by applicant]
Sadelain, M. et al., Safe harbours for the integration of new DNA in the human genome, Nature Reviews Cancer, 12:51-58 (2012). [cited by applicant]
Sandberg, H. et al., Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ, Thromb. Haemost., 85(1):93-100 (2001). [cited by applicant]
Sanglioglu, A.D. et al., Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction, Virus Res., 104(1):51-59 (2004). [cited by applicant]
Santosh, V. et al., The Cryo-EM structure of AAV2 Rep68 in complex with ssDNA reveals a malleable AAA+ machine that can switch between oligomeric states, Nucleic Acids Res., 48(22):12983-12999 (2020). [cited by applicant]
Sather, B.D. et al., Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template, Sci. Transl. Med., 7(307):307ra156 (2015). [cited by applicant]
Schambach, A. et al., Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors, Mol. Ther., 15(6):1167-1173 (2007). [cited by applicant]
Schek, N. et al., Definition of the Upstream Efficiency Element of the Simian Virus 40 Late Polyadenylation Signal by Using in Vitro Analyses, Mol. Cell Biol., 12(12):5386-5393 (1992). [cited by applicant]
Schoning, K. et al., Chemical etiology of nucleic acid structure: the alpha-threofuranosyl-(3′-->2′) oligonucleotide system, Science, 290(5495):1347-1351 (2000). [cited by applicant]
Seth, P.P. et al., An exocyclic methylene group acts as a bioisostere of the 2′-oxygen atom in LNA, J. Am. Chem. Soc., 132(42):14942-14950 (2010). [cited by applicant]
Sharp, C.P. et al., High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies, J. Infect. Dis., 200(7):1119-1125 (… [cited by applicant]
Sharp, P.A., RNAi and double-strand RNA, Genes. Dev., 13(2):139-141 (1999). [cited by applicant]
Shen, W. et al., Analysis of cis and trans Requirements for DNA Replication at the Right-End Hairpin of the Human Bocavirus 1 Genome, J. Virol., 90(17):7761-7777 (2016). [cited by applicant]
Shen, W. et al., Hairpin Transfer—Independent Parvovirus DNA Replication Produces Infectious Virus, J. Virol., 95(20):e0110821 (2021). [cited by applicant]
Shen, W. et al., Identification and Functional Analysis of Novel Nonstructural Proteins of Human Bocavirus 1, J. Virol., 89(19):10097-10109 (2015). [cited by applicant]
Shmakov, S. et al., Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems, Mol. Cell., 60(3):385-397 (2015). [cited by applicant]